Fluticasone propionate aerosol for the treatment of adults with mild to moderate asthma
- 31 October 1994
- journal article
- clinical trial
- Published by Elsevier in Journal of Allergy and Clinical Immunology
- Vol. 94 (4) , 676-683
- https://doi.org/10.1016/0091-6749(94)90174-0
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Comparison of the efficacy and safety of inhaled fluticasone propionate 200 micrograms/day with inhaled beclomethasone dipropionate 400 micrograms/day in mild and moderate asthma.Archives of Disease in Childhood, 1993
- Comparison of fluticasone propionate with beclomethasone dipropionate in moderate to severe asthma treated for one year. International Study Group.Thorax, 1993
- Comparison of oral-steroid sparing by high-dose and low-dose inhaled steroid in maintenance treatment of severe asthmaThe Lancet, 1992
- Inhaled corticosteroids: benefits and risks.Thorax, 1992
- Structure-activity relationships of topically active steroids: the selection of fluticasone propionateRespiratory Medicine, 1990
- The human pharmacology of fluticasone propionateRespiratory Medicine, 1990
- Six-Month Double-Blind, Controlled Trial of High Dose, Concentrated Beclomethasone Dipropionate in the Treatment of Severe Chronic AsthmaChest, 1988
- A graded dose assessment of the efficacy of beclomethasone dipropionate aerosol for severe chronic asthmaJournal of Allergy and Clinical Immunology, 1977
- Response of patients receiving high dose beclomethasone dipropionateThorax, 1974
- AEROSOL BECLOMETHASONE DIPROPIONATE: A DOSE-RESPONSE STUDY IN CHRONIC BRONCHIAL ASTHMAThe Lancet, 1973